| News

The pharma centers of Basel and India are influencing each other

21.02.2020

Basel has long been one of the world’s most important locations within the pharmaceutical industry. But pharma firms are now starting to play an even bigger role in India as well. Both locations are influencing each other, as shown by the recently ended BioAsia event.

Anke Hollnagel, Director Asia at BaselArea.swiss

Large Indian pharma companies are currently focusing on generics and biosimilars in particular, while Basel-based firms such as Novartis and Roche carry out large-scale research projects, as detailed in a guest article on swissinfo.ch by Anke Hollnagel, Director Asia of the local business promotion organization BaselArea.swiss. However, there are also parallels and mutually beneficial influences between the two locations.

In this way, four startups based in Basel – namely Cellestia, Bottmedical, Artidis und Noul – presented their businesses within the framework of the BioAsia India event, which was held in Hyderabad on February 17-20, 2020. The Swiss delegation came at the initiative of Switzerland Global Enterprise (S-GE), a Swiss foreign trade promotion organization. The delegation also included representatives from BaselArea.swiss, which promoted the economic area of Basel at the event.

However, the interest is ever stronger in the other direction, as Anke Hollnagel notes in her article. In this context, Basel is becoming an attractive location for ever more Indian firms. These companies are active particularly in the areas of the Internet of Things (IoT), Artificial Intelligence (AI) and Machine Learning, and they are offering their services to Basel-based firms operating in the field of life sciences. In this way, they are driving the development of the life sciences sector towards digital healthcare and data-led personalized medicine. According to Anke Hollnagel, this influence will increase yet further over the coming years as Indian firms develop. The major Indian pharma group Dr. Reddy’s has already established a strong presence in Basel.

BaselArea.swiss recognized this development a long time ago and has placed a stronger focus on the Indian market in the past year. This focus will be sustained throughout 2020 as well.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area Business & Innovation, Innovation

docdok.health involved in coronavirus research project

A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.

Read More
Basel Area Business & Innovation, Innovation

Celonic agrees cooperation to combat coronavirus

The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two companies are planning to develop a drug to treat coronavirus.

Read More
Basel Area Business & Innovation, Innovation, Invest

Idorsia receives payment of 45 million US dollars

The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..

Read More
Basel Area Business & Innovation, Innovation

Humard robot disinfects using UV light

Humard has developed a robot that can disinfect spaces using UV light. For this, the system manufacturer from the canton of Jura has adapted a mobile industrial robot that is otherwise used in warehouse logistics.

Read More
Basel Area Business & Innovation, Innovation, Invest

Roche authorized to distribute coronavirus antibody tests

Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.

Read More
Basel Area Business & Innovation, Invest

Basel is the most popular Swiss location for headquarters

Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.

Read More
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Healthtech sector growing rapidly in the Basel Area

The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.

Read More
Basel Area Business & Innovation, Innovation, Invest

Support program has roots in Basel

The online program Selfapy supports people suffering from mental health conditions during the coronavirus lockdown. BaselArea.swiss has provided startup help by way of its DayOne initiative.

Read More
Basel Area Business & Innovation, Innovation

University Hospital Basel treats coronavirus patients with plasma

The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.

Read More
Basel Area Business & Innovation, Innovation

Botnar Research Center advancing research into coronavirus

The Basel-based Botnar Research Center for Child Health is providing capital in the amount of 15 million Swiss francs to its four partner institutions. In this way, the University of Basel should be in a position to advance research into dealing with the coronavirus outbreak.

Read More
1 2 3 18

Do you have a question? We'd like to hear from you.